Literature DB >> 31695732

Anaemia and transfusion triggers in critically ill patients - What we have learnt thus far.

Amritpal Singh Jandu1, Steven Vidgeon2, Nadeem Ahmed2.   

Abstract

Anaemia is a common finding in critically ill patients, the cause of which is multi-factorial including: sepsis, haemolysis (and disseminated intravascular coagulation), iatrogenic blood loss secondary to laboratory sampling, post-operative anaemia, bone marrow suppression/failure, decreased production of erythropoietin, anaemia secondary to drugs/toxins, overt or occult blood loss, functional iron deficiency, poor nutrition and haemodilution. Anaemia is associated with deleterious outcomes including increased risk of cardiac-related morbidity and mortality and decrease in oxygen-carrying capacity in the face of increased metabolic demands. There is a growing body of evidence, which demonstrates that packed red blood cell transfusions are associated with poorer outcomes. Clinicians therefore need to weigh the potential benefit of treating anaemia against the desire to avoid unnecessary transfusions. We explored current literature regarding transfusion triggers and morbidity and mortality associated with packed red blood cell transfusions transfusion, concentrating on studies that have been conducted in critical care patients. In addition, we reflected on trials which considered the viability of iron transfusion and erythropoietin in critically unwell patients. © The Intensive Care Society 2018.

Entities:  

Keywords:  Anaemia; critical care; erythropoietin; iron transfusions; transfusion triggers

Year:  2018        PMID: 31695732      PMCID: PMC6820222          DOI: 10.1177/1751143718783615

Source DB:  PubMed          Journal:  J Intensive Care Soc        ISSN: 1751-1437


  28 in total

Review 1.  Proposed mechanisms of transfusion-induced immunomodulation.

Authors:  S A Kirkley
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

Review 2.  Erythropoietin: structure, control of production, and function.

Authors:  W Jelkmann
Journal:  Physiol Rev       Date:  1992-04       Impact factor: 37.312

Review 3.  Blood transfusion-induced immunomodulation.

Authors:  D F Landers; G E Hill; K C Wong; I J Fox
Journal:  Anesth Analg       Date:  1996-01       Impact factor: 5.108

4.  Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial.

Authors:  Howard L Corwin; Andrew Gettinger; Ronald G Pearl; Mitchell P Fink; Mitchell M Levy; Marc J Shapiro; Michael J Corwin; Theodore Colton
Journal:  JAMA       Date:  2002-12-11       Impact factor: 56.272

5.  Lower versus higher hemoglobin threshold for transfusion in septic shock.

Authors:  Lars B Holst; Nicolai Haase; Jørn Wetterslev; Jan Wernerman; Anne B Guttormsen; Sari Karlsson; Pär I Johansson; Anders Aneman; Marianne L Vang; Robert Winding; Lars Nebrich; Helle L Nibro; Bodil S Rasmussen; Johnny R M Lauridsen; Jane S Nielsen; Anders Oldner; Ville Pettilä; Maria B Cronhjort; Lasse H Andersen; Ulf G Pedersen; Nanna Reiter; Jørgen Wiis; Jonathan O White; Lene Russell; Klaus J Thornberg; Peter B Hjortrup; Rasmus G Müller; Morten H Møller; Morten Steensen; Inga Tjäder; Kristina Kilsand; Suzanne Odeberg-Wernerman; Brit Sjøbø; Helle Bundgaard; Maria A Thyø; David Lodahl; Rikke Mærkedahl; Carsten Albeck; Dorte Illum; Mary Kruse; Per Winkel; Anders Perner
Journal:  N Engl J Med       Date:  2014-10-01       Impact factor: 91.245

6.  Red blood cell transfusions worsen the outcomes even in critically ill patients undergoing a restrictive transfusion strategy.

Authors:  João Manoel da Silva Junior; Ederlon Rezende; Cristina Prada Amendola; Rafael Tomita; Daniele Torres; Maria Tereza Ferrari; Diogo Oliveira Toledo; Amanda Maria Ribas Rosa Oliveira; Juliana Andreia Marques
Journal:  Sao Paulo Med J       Date:  2012       Impact factor: 1.044

Review 7.  Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature.

Authors:  Paul E Marik; Howard L Corwin
Journal:  Crit Care Med       Date:  2008-09       Impact factor: 7.598

8.  Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial : A randomized trial of IV iron in critical illness.

Authors:  Edward Litton; Stuart Baker; Wendy N Erber; Shannon Farmer; Janet Ferrier; Craig French; Joel Gummer; David Hawkins; Alisa Higgins; Axel Hofmann; Bart De Keulenaer; Julie McMorrow; John K Olynyk; Toby Richards; Simon Towler; Robert Trengove; Steve Webb
Journal:  Intensive Care Med       Date:  2016-09-30       Impact factor: 17.440

Review 9.  Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis.

Authors:  Lars B Holst; Marie W Petersen; Nicolai Haase; Anders Perner; Jørn Wetterslev
Journal:  BMJ       Date:  2015-03-24

10.  Iron supplementation to treat anaemia in adult critical care patients: a systematic review and meta-analysis.

Authors:  Akshay Shah; Noémi B Roy; Stuart McKechnie; Carolyn Doree; Sheila A Fisher; Simon J Stanworth
Journal:  Crit Care       Date:  2016-09-29       Impact factor: 9.097

View more
  3 in total

Review 1.  Iron-withdrawing anti-infectives for new host-directed therapies based on iron dependence, the Achilles' heel of antibiotic-resistant microbes.

Authors:  Bruce E Holbein; M Trisha C Ang; David S Allan; Wangxue Chen; Christian Lehmann
Journal:  Environ Chem Lett       Date:  2021-04-23       Impact factor: 9.027

2.  A Cohort Study in Intensive Care Units: Health Decisions Related to Blood Transfusion during the COVID-19 Pandemic.

Authors:  Raúl Juárez-Vela; José Antonio García-Erce; Vicente Gea-Caballero; Regina Ruiz de Viñaspre-Hernandez; José Ángel Santos-Sánchez; Juan Luis Sánchez-González; Eva María Andrés-Esteban; Michał Czapla; Clara Isabel Tejada; Kapil Laxman Nanwani-Nanwani; Ainhoa Serrano-Lázaro; Manuel Quintana-Díaz
Journal:  J Clin Med       Date:  2022-07-28       Impact factor: 4.964

Review 3.  Thresholds for blood transfusion in extremely preterm infants: A review of the latest evidence from two large clinical trials.

Authors:  Michael P Meyer; Kristin L O'Connor; Jill H Meyer
Journal:  Front Pediatr       Date:  2022-09-20       Impact factor: 3.569

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.